Manufacturer record
A.N.D Healthcare Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by A.N.D Healthcare Ltd (Punjab) were declared Not of Standard Quality between January 2025 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: NBT-251045, Nicoz-5 Nicorandil Tablets IP 5 mg (exp Sep 2027). RDTL Ernakulam (state lab) found it not of standard quality: Sample does not conform to IP Standards. If fails the test 'Dissolution' and 'Assay'. Listed in the July 2026 alert.
Records by type
2 records linked to A.N.D Healthcare Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Nicoz-5 Nicorandil Tablets IP 5 mg | Batch NBT-251045Mfg Oct 2025 · Exp Sep 2027 | Sample does not conform to IP Standards. If fails the test 'Dissolution' and 'Assay'Assay | RDTL ErnakulamState lab | Jul 2026 |
| Cefixime and Lactic Acid Bacillus Tablets (CEFIZOC-200 LB TABLETS) | Batch BT-240511Mfg May 2024 · Exp Apr 2026 | Assay of Lactic Acid BacillusAssay | RDTL ChandigarhCDSCO lab | Jan 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.